95 related articles for article (PubMed ID: 8028752)
21. [The correlation between serum thyroglobulin and iodine-131 scanning in detecting metastases in patients with a differentiated thyroid carcinoma].
Abduluakhab M; Gavrilov M; Mladenov B
Khirurgiia (Sofiia); 1997; 50(4):33-6. PubMed ID: 9739856
[TBL] [Abstract][Full Text] [Related]
22. Surgical treatment of papillary and follicular thyroid carcinoma.
Lin JD; Jeng LB; Chao TC; Weng HF; Huang HS
Int Surg; 1996; 81(1):61-6. PubMed ID: 8803709
[TBL] [Abstract][Full Text] [Related]
23. Evaluation of the diagnostic value of the first thyroglobulin determination in detecting metastases after differentiated thyroid carcinoma surgery.
Makarewicz J; Adamczewski Z; Knapska-Kucharska M; Lewiński A
Exp Clin Endocrinol Diabetes; 2006 Oct; 114(9):485-9. PubMed ID: 17115345
[TBL] [Abstract][Full Text] [Related]
24. [Use of tumor markers in monitoring thyroid carcinoma].
Gorgone S; Lazzara S; Palmeri R; Belnome N; Calbo L; Dattola P; Melita P
Chir Ital; 1987 Feb; 39(1):87-95. PubMed ID: 3607983
[TBL] [Abstract][Full Text] [Related]
25. [Controversies in the follow-up and management of well-differentiated thyroid cancer. New answers to old questions].
Abós Olivares MD; Pesquera González C
Rev Esp Med Nucl; 2005; 24(3):207-15. PubMed ID: 15847791
[No Abstract] [Full Text] [Related]
26. [Recovery test or immunoradiometric measurement of anti-thyroglobulin autoantibodies for interpretation of thyroglobulin determination in the follow-up of different thyroid carcinoma].
Zöphel K; Wunderlich G; Liepach U; Koch R; Bredow J; Franke WG
Nuklearmedizin; 2001 Oct; 40(5):155-63. PubMed ID: 11727628
[TBL] [Abstract][Full Text] [Related]
27. [Standards, options and recommendations for blood tumor markers in thyroid cancers].
Pichon MF; Basuyau JP; Gory-Delabaere G; Eche N; Daver A; Blanc-Vincent MP; Riedinger JM; Deneux L; Bidart JM
Bull Cancer; 2001 Aug; 88(8):775-92. PubMed ID: 11578946
[TBL] [Abstract][Full Text] [Related]
28. [Therapy concept in differentiated thyroid gland carcinoma--results of 25 years with 257 patients].
Gemsenjäger E; Heitz PU; Martina B; Schweizer I
Praxis (Bern 1994); 2000 Nov; 89(44):1779-97. PubMed ID: 11109916
[TBL] [Abstract][Full Text] [Related]
29. [Prospective therapy study in differentiated thyroid carcinoma].
Gemsenjäger E; Heitz P; Martina B
Schweiz Med Wochenschr; 1995 Nov; 125(46):2226-36. PubMed ID: 8525342
[TBL] [Abstract][Full Text] [Related]
30. Clinicopathologic significance of histologic vascular invasion in papillary and follicular thyroid carcinomas.
Furlan JC; Bedard YC; Rosen IB
J Am Coll Surg; 2004 Mar; 198(3):341-8. PubMed ID: 14992733
[TBL] [Abstract][Full Text] [Related]
31. Neck recurrence from thyroid carcinoma: serum thyroglobulin and high-dose total body scan are not reliable criteria for cure after radioiodine treatment.
Bachelot A; Leboulleux S; Baudin E; Hartl DM; Caillou B; Travagli JP; Schlumberger M
Clin Endocrinol (Oxf); 2005 Mar; 62(3):376-9. PubMed ID: 15730423
[TBL] [Abstract][Full Text] [Related]
32. [Thyroid carcinoma: evaluation of prognostic factors].
d'Annibale M; Piovanello P; Appetecchia M; Grauso F; Bruno PL; Perri P; Piarulli L
Chir Ital; 1999; 51(1):59-64. PubMed ID: 10514918
[TBL] [Abstract][Full Text] [Related]
33. [Surgical treatment of differentiated thyroid carcinoma].
Guercioni G; Siquini W; Taccaliti A; Marmorale C
Ann Ital Chir; 2003; 74(5):501-9. PubMed ID: 15139704
[TBL] [Abstract][Full Text] [Related]
34. [Surgical treatment of differentiated carcinoma of the thyroid. Follow-up of 99 cases].
Pozzetto B; Roseano M; Dellach C; Leggeri A
Chir Ital; 2000; 52(1):49-56. PubMed ID: 10832526
[TBL] [Abstract][Full Text] [Related]
35. [Clinical analysis of 88 elderly patients with thyroid cancer].
Gong JP; Zhang RX; Cheng HQ
Zhonghua Zhong Liu Za Zhi; 2007 Feb; 29(2):150. PubMed ID: 17645857
[No Abstract] [Full Text] [Related]
36. [Advantages of completion thyroidectomy as a second stage for differentiated thyroid cancer].
Lachkhem A; Khamassi K; Touati S; Charrada K; Ben Miled M; Oueslati Z; El May A; Ben Slimène F; Gritli S
J Chir (Paris); 2009 Oct; 146(5):520-1. PubMed ID: 19833337
[No Abstract] [Full Text] [Related]
37. Rising thyroglobulin tumour marker during pregnancy in a thyroid cancer patient: no cause for alarm?
Murray JR; Williams GR; Harrington KJ; Newbold K; Nutting CM
Clin Endocrinol (Oxf); 2012 Jul; 77(1):155-7. PubMed ID: 22171652
[No Abstract] [Full Text] [Related]
38. Analysis of Tg transcripts by real-time RT-PCR in the blood of thyroid cancer patients.
Savagner F; Rodien P; Reynier P; Rohmer V; Bigorgne JC; Malthiery Y
J Clin Endocrinol Metab; 2002 Feb; 87(2):635-9. PubMed ID: 11836297
[TBL] [Abstract][Full Text] [Related]
39. [Tumor markers for thyroid malignant disease].
Tamura K
Nihon Rinsho; 2011 Mar; 69 Suppl 2():298-303. PubMed ID: 21830558
[No Abstract] [Full Text] [Related]
40. [Tumor markers in the diagnosis of thyroid cancer].
Slavnov VN; Markov VV; Kovalenko AE; Kovpan NA; Kvacheniuk AN
Lik Sprava; 1997; (4):31-4. PubMed ID: 9471369
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
